Hypertrophic cardiomyopathy with progression from apical hypertrophy to asymmetrical septal hypertrophy: a case

Hiroaki Kitaoka1, Tomoo Kuwahara, Koji Nishida

  • 1Cardiology Division, Department of Medicine and Geriatrics, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi 783-8505. kitaokah@med.kochi-u.ac.jp

Insights

This study documents a rare case of hypertrophic cardiomyopathy evolving over ten years. Initial apical hypertrophy transformed into asymmetrical septal hypertrophy, highlighting disease progression.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Genetic Cardiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease.
  • Apical hypertrophic cardiomyopathy (AHC) is a distinct subtype characterized by distal left ventricular hypertrophy.
  • Morphological changes in HCM can occur over time, but progression from AHC to other forms is less commonly documented.

Observation:

  • A 41-year-old male presented with abnormal electrocardiography findings.
  • Initial transthoracic echocardiography revealed left ventricular hypertrophy localized to the distal left ventricle, consistent with AHC.
  • A decade later, the patient experienced chest pain, and repeat echocardiography demonstrated superimposed asymmetrical septal hypertrophy.

Findings:

  • The case illustrates a dynamic morphologic evolution of hypertrophic cardiomyopathy.
  • The progression from isolated apical hypertrophy to combined apical and asymmetrical septal hypertrophy was observed over a 10-year period.
  • This suggests that hypertrophic cardiomyopathy can exhibit significant changes in left ventricular morphology over time.

Implications:

  • This case highlights the potential for hypertrophic cardiomyopathy to undergo significant morphological transformation.
  • Understanding such evolutionary patterns is crucial for accurate diagnosis, risk stratification, and long-term management of HCM patients.
  • Further research into the mechanisms driving these morphologic changes may offer new therapeutic targets.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...